Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70
2021-07-02 05:32
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany
2021-07-01 21:00
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
2021-07-01 20:00
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's
2021-07-01 19:50
Elliott Publishes Letter on GlaxoSmithKline
2021-07-01 14:45
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
2021-06-30 22:00
I-Mab Honored with Top Rankings by Institutional Investor
2021-06-30 20:00
Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines
2021-06-30 20:00
Akeso Awarded as 2021 "Most Honored Company" by Institutional Investor
2021-06-30 16:00
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
2021-06-30 16:00
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility
2021-06-30 16:00
Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container
2021-06-30 14:48
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
2021-06-30 09:29
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
2021-06-29 20:13
I-Mab Announces Upcoming Participation at July Conference
2021-06-29 20:00
Medical Affairs Teams are Increasingly Turning to Patient-centric Analytics to Improve Clinical Outcomes
2021-06-29 18:02
Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities
2021-06-29 18:00
Lianhua Qingwen Granted Market Access as Medicine in Ukraine: Yiling Pharmaceutical
2021-06-29 16:41
First in China! Neurophth announced the first patient has been dosed in G.O.L.D. clinical trial for the gene therapy treatment of LHON
2021-06-28 21:33
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury
2021-06-28 20:00
1
236
237
238
239
240
413